Literature DB >> 23541841

Reference values for major depression questionnaires: the Leiden Routine Outcome Monitoring Study.

Yvonne W M Schulte-van Maaren1, Ingrid V E Carlier, Frans G Zitman, Albert M van Hemert, Margot W M de Waal, A J Willem van der Does, Martijn S van Noorden, Erik J Giltay.   

Abstract

BACKGROUND: The Beck Depression Inventory-II (BDI-II), the Inventory of Depressive Symptoms (self-report) (IDS-SR) and the Montgomery-Äsberg Depression Rating Scale (MADRS) are questionnaires that assess symptom severity in patients with a depressive disorder, often part of Routine Outcome Monitoring (ROM). We aimed to generate reference values for both "healthy" and "clinically depressed" populations.
METHODS: We included 1295 subjects from the general population (ROM reference-group) recruited through general practitioners, and 4627 psychiatric outpatients diagnosed with Major Depressive Disorder (MDD) or dysthymia (ROM patient-group). The outermost 5% of observations were used to define limits for one-sided reference intervals (95th percentiles; P95). Receiver Operating Characteristics (ROC) analyses were used to yield alternative cut-off values. Internal consistency was assessed.
RESULTS: The mean age was 40.3yr (SD=12.6) and 39.3 (SD=12.3) for the ROM reference and patient-groups, respectively, and 62.8% versus 61.0% were female. Cut-off (P95) values differed for women and men, being respectively 15 and 12 for the BDI-II, 23 and 18 for the IDS-SR, and 12.5 and 9 for the MADRS. ROC analyses yielded almost equal reference values. The discriminative power of the BDI-II, IDS-SR and MADRS scores was very high. Internal consistency was excellent for total scores and satisfactory for all subscales, except for the IDS-SR subscale Atypical Characteristics. LIMITATIONS: Substantial non-response and limited generalizability.
CONCLUSIONS: For the BDI-II, IDS-SR and MADRS a comprehensive set of reference values were provided. Reference values were higher in women than in men, implying the use of sex-specific cut-off values. Either instrument can be offered to every patient with MAS disorders to make responsible decisions about continuing, changing or terminating therapy.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23541841     DOI: 10.1016/j.jad.2013.02.009

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  12 in total

Review 1.  How depressed is "depressed"? A systematic review and diagnostic meta-analysis of optimal cut points for the Beck Depression Inventory revised (BDI-II).

Authors:  Michael von Glischinski; Ruth von Brachel; Gerrit Hirschfeld
Journal:  Qual Life Res       Date:  2018-11-19       Impact factor: 4.147

2.  The scars of childhood adversity: minor stress sensitivity and depressive symptoms in remitted recurrently depressed adult patients.

Authors:  Gemma Kok; Gerard van Rijsbergen; Huibert Burger; Hermien Elgersma; Heleen Riper; Pim Cuijpers; Jack Dekker; Filip Smit; Claudi Bockting
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

3.  Depressive symptoms, life satisfaction and prevalence of sleep disturbances in the general population of Germany: results from the Heinz Nixdorf Recall study.

Authors:  Maria Elena Lacruz; Andrea Schmidt-Pokrzywniak; Nico Dragano; Susanne Moebus; Susanne Eva Deutrich; Stefan Möhlenkamp; Axel Schmermund; Hagen Kaelsch; Raimund Erbel; Andreas Stang
Journal:  BMJ Open       Date:  2016-01-04       Impact factor: 2.692

4.  Treating winter depressive episodes in bipolar disorder: an open trial of light therapy.

Authors:  Lotte J E van Hout; Lisette E P Rops; Claudia J P Simons
Journal:  Int J Bipolar Disord       Date:  2020-06-01

5.  Measurement properties of tools used to assess depression in adults with and without autism spectrum conditions: A systematic review.

Authors:  S A Cassidy; L Bradley; E Bowen; S Wigham; J Rodgers
Journal:  Autism Res       Date:  2018-01-23       Impact factor: 5.216

6.  Guided Internet-based cognitive behavioral therapy for mild and moderate depression: A benchmarking study.

Authors:  Hanne Jakobsen; Gerhard Andersson; Odd E Havik; Tine Nordgreen
Journal:  Internet Interv       Date:  2016-11-15

7.  Effects of the COVID-19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms.

Authors:  Manja Koenders; Rahele Mesbah; Annet Spijker; Elvira Boere; Max de Leeuw; Bert van Hemert; Erik Giltay
Journal:  Brain Behav       Date:  2021-09-23       Impact factor: 2.708

8.  Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder.

Authors:  Erika Comasco; Inger Sundström Poromaa; Anna Wikman; Julia Sacher; Marie Bixo; Angelica L Hirschberg; Helena Kopp Kallner; C Neill Epperson
Journal:  BMC Womens Health       Date:  2022-02-11       Impact factor: 2.809

9.  Seasonality of mood and affect in a large general population sample.

Authors:  Wim H Winthorst; Elisabeth H Bos; Annelieke M Roest; Peter de Jonge
Journal:  PLoS One       Date:  2020-09-14       Impact factor: 3.240

10.  Personalized ESM monitoring and feedback to support psychological treatment for depression: a pragmatic randomized controlled trial (Therap-i).

Authors:  H Riese; L von Klipstein; R A Schoevers; D C van der Veen; M N Servaas
Journal:  BMC Psychiatry       Date:  2021-03-10       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.